Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Alcoholic liver disease 💬
1件: IL17A 💬 Bimekizumab 💬 Bimekizumab 3件: 46, 97, 271 💬
2 Alcoholic liver disease 💬
1件: IL17A 💬 Ixekizumab 💬 Ixekizumab 8件: 36, 37, 46, 107, 160, 162, 269, 271 💬
3 Alcoholic liver disease 💬
1件: IL17A 💬 Secukinumab 💬 Secukinumab 8件: 13, 37, 41, 46, 107, 160, 269, 271 💬
4 Alcoholic liver disease 💬
1件: IL17A 💬 Tibulizumab 💬 Tibulizumab 1件: 53 💬
5 Cytokine-cytokine receptor interaction 💬
1件: IL17A 💬 Ixekizumab 💬 Ixekizumab 8件: 36, 37, 46, 107, 160, 162, 269, 271 💬
6 Cytokine-cytokine receptor interaction 💬
1件: IL17A 💬 Secukinumab 💬 Secukinumab 8件: 13, 37, 41, 46, 107, 160, 269, 271 💬
7 Cytokine-cytokine receptor interaction 💬
2件: IL17A, IL17F 💬 Bimekizumab 💬 Bimekizumab 3件: 46, 97, 271 💬
8 Cytokine-cytokine receptor interaction 💬
2件: IL17A, TNFSF13B 💬 Tibulizumab 💬 Tibulizumab 1件: 53 💬
9 IL-17 signaling pathway 💬
1件: IL17A 💬 Ixekizumab 💬 Ixekizumab 8件: 36, 37, 46, 107, 160, 162, 269, 271 💬
10 IL-17 signaling pathway 💬
1件: IL17A 💬 Secukinumab 💬 Secukinumab 8件: 13, 37, 41, 46, 107, 160, 269, 271 💬
11 IL-17 signaling pathway 💬
1件: IL17A 💬 Tibulizumab 💬 Tibulizumab 1件: 53 💬
12 IL-17 signaling pathway 💬
2件: IL17A, IL17F 💬 Bimekizumab 💬 Bimekizumab 3件: 46, 97, 271 💬
13 Inflammatory bowel disease 💬
1件: IL17A 💬 Ixekizumab 💬 Ixekizumab 8件: 36, 37, 46, 107, 160, 162, 269, 271 💬
14 Inflammatory bowel disease 💬
1件: IL17A 💬 Secukinumab 💬 Secukinumab 8件: 13, 37, 41, 46, 107, 160, 269, 271 💬
15 Inflammatory bowel disease 💬
1件: IL17A 💬 Tibulizumab 💬 Tibulizumab 1件: 53 💬
16 Inflammatory bowel disease 💬
2件: IL17A, IL17F 💬 Bimekizumab 💬 Bimekizumab 3件: 46, 97, 271 💬
17 Rheumatoid arthritis 💬
1件: IL17A 💬 Bimekizumab 💬 Bimekizumab 3件: 46, 97, 271 💬
18 Rheumatoid arthritis 💬
1件: IL17A 💬 Ixekizumab 💬 Ixekizumab 8件: 36, 37, 46, 107, 160, 162, 269, 271 💬
19 Rheumatoid arthritis 💬
1件: IL17A 💬 Secukinumab 💬 Secukinumab 8件: 13, 37, 41, 46, 107, 160, 269, 271 💬
20 Rheumatoid arthritis 💬
2件: IL17A, TNFSF13B 💬 Tibulizumab 💬 Tibulizumab 1件: 53 💬
21 Th17 cell differentiation 💬
1件: IL17A 💬 Ixekizumab 💬 Ixekizumab 8件: 36, 37, 46, 107, 160, 162, 269, 271 💬
22 Th17 cell differentiation 💬
1件: IL17A 💬 Secukinumab 💬 Secukinumab 8件: 13, 37, 41, 46, 107, 160, 269, 271 💬
23 Th17 cell differentiation 💬
1件: IL17A 💬 Tibulizumab 💬 Tibulizumab 1件: 53 💬
24 Th17 cell differentiation 💬
2件: IL17A, IL17F 💬 Bimekizumab 💬 Bimekizumab 3件: 46, 97, 271 💬